Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study
Abstract Background The nephrotoxicity associated with polymyxins is a critical safety concern in clinical practice. The aim of this study was to compare the nephrotoxicity of patients treated with colistin sulfate (CS) and colistin methanesulfonate (CMS). Methods Data on inpatients who received int...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11401-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343949485899776 |
|---|---|
| author | Ping Yang Wuping Shuai Yuanzhi Ju Hongping Zhu Rongrong Wang Xiaoyang Lu Saiping Jiang |
| author_facet | Ping Yang Wuping Shuai Yuanzhi Ju Hongping Zhu Rongrong Wang Xiaoyang Lu Saiping Jiang |
| author_sort | Ping Yang |
| collection | DOAJ |
| description | Abstract Background The nephrotoxicity associated with polymyxins is a critical safety concern in clinical practice. The aim of this study was to compare the nephrotoxicity of patients treated with colistin sulfate (CS) and colistin methanesulfonate (CMS). Methods Data on inpatients who received intravenous colistin (CS) or colistin methanesulfonate (CMS) for over 72 h were collected from January to December 2023. The primary outcome was the incidence of acute kidney injury (AKI) associated with polymyxins, while the secondary outcome was 30-day all-cause mortality. Furthermore, Cox proportional hazard regression analysis was used to identify the risk factors of polymyxin-induced AKI. Results A total of 291 patients were included in this study. The overall incidence of AKI was significantly higher in patients who received CMS compared to those who received CS in the unmatched cohort (29.70% vs. 7.37%) and in the propensity score matching (PSM) cohort (26.30% vs. 10.00%), respectively. However, 30-day all-cause mortality was significantly higher in the CS cohort than in the CMS cohort before (27.37% vs. 15.84%) and after (33.75% vs. 15.00%) PSM. CMS therapy and a lower baseline estimated glomerular filtration rate (eGFR) were identified as independent risk factors for polymyxin-induced AKI. Conclusions This was the first study to investigate the nephrotoxicity difference between CS and CMS to our best knowledge. In this study, the incidence rate of AKI was significantly lower in the CS cohort compared with the CMS cohort, however, 30-day all-cause mortality rate was significantly higher in the CS cohort than in the CMS cohort. Further validation of these findings requires more prospective multicentre studies with a large sample size. |
| format | Article |
| id | doaj-art-c30ea9f0de1743978f966d75ef4d9950 |
| institution | Kabale University |
| issn | 1471-2334 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj-art-c30ea9f0de1743978f966d75ef4d99502025-08-20T03:42:48ZengBMCBMC Infectious Diseases1471-23342025-08-0125111210.1186/s12879-025-11401-8Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort studyPing Yang0Wuping Shuai1Yuanzhi Ju2Hongping Zhu3Rongrong Wang4Xiaoyang Lu5Saiping Jiang6Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of MedicineResearch Center for Clinical Pharmacy, College of Pharmaceutical Sciences, Zhejiang UniversityDepartment of Pharmacy, the Second Affiliated Hospital of Nanchang UniversityDepartment of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of MedicineAbstract Background The nephrotoxicity associated with polymyxins is a critical safety concern in clinical practice. The aim of this study was to compare the nephrotoxicity of patients treated with colistin sulfate (CS) and colistin methanesulfonate (CMS). Methods Data on inpatients who received intravenous colistin (CS) or colistin methanesulfonate (CMS) for over 72 h were collected from January to December 2023. The primary outcome was the incidence of acute kidney injury (AKI) associated with polymyxins, while the secondary outcome was 30-day all-cause mortality. Furthermore, Cox proportional hazard regression analysis was used to identify the risk factors of polymyxin-induced AKI. Results A total of 291 patients were included in this study. The overall incidence of AKI was significantly higher in patients who received CMS compared to those who received CS in the unmatched cohort (29.70% vs. 7.37%) and in the propensity score matching (PSM) cohort (26.30% vs. 10.00%), respectively. However, 30-day all-cause mortality was significantly higher in the CS cohort than in the CMS cohort before (27.37% vs. 15.84%) and after (33.75% vs. 15.00%) PSM. CMS therapy and a lower baseline estimated glomerular filtration rate (eGFR) were identified as independent risk factors for polymyxin-induced AKI. Conclusions This was the first study to investigate the nephrotoxicity difference between CS and CMS to our best knowledge. In this study, the incidence rate of AKI was significantly lower in the CS cohort compared with the CMS cohort, however, 30-day all-cause mortality rate was significantly higher in the CS cohort than in the CMS cohort. Further validation of these findings requires more prospective multicentre studies with a large sample size.https://doi.org/10.1186/s12879-025-11401-8Colistin sulfateColistimethate sodiumAcute kidney injuryNephrotoxicity30-day mortality |
| spellingShingle | Ping Yang Wuping Shuai Yuanzhi Ju Hongping Zhu Rongrong Wang Xiaoyang Lu Saiping Jiang Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study BMC Infectious Diseases Colistin sulfate Colistimethate sodium Acute kidney injury Nephrotoxicity 30-day mortality |
| title | Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study |
| title_full | Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study |
| title_fullStr | Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study |
| title_full_unstemmed | Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study |
| title_short | Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study |
| title_sort | acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium a real world retrospective cohort study |
| topic | Colistin sulfate Colistimethate sodium Acute kidney injury Nephrotoxicity 30-day mortality |
| url | https://doi.org/10.1186/s12879-025-11401-8 |
| work_keys_str_mv | AT pingyang acutekidneyinjuryofintravenouscolistinsulfatecomparedwithcolistimethatesodiumarealworldretrospectivecohortstudy AT wupingshuai acutekidneyinjuryofintravenouscolistinsulfatecomparedwithcolistimethatesodiumarealworldretrospectivecohortstudy AT yuanzhiju acutekidneyinjuryofintravenouscolistinsulfatecomparedwithcolistimethatesodiumarealworldretrospectivecohortstudy AT hongpingzhu acutekidneyinjuryofintravenouscolistinsulfatecomparedwithcolistimethatesodiumarealworldretrospectivecohortstudy AT rongrongwang acutekidneyinjuryofintravenouscolistinsulfatecomparedwithcolistimethatesodiumarealworldretrospectivecohortstudy AT xiaoyanglu acutekidneyinjuryofintravenouscolistinsulfatecomparedwithcolistimethatesodiumarealworldretrospectivecohortstudy AT saipingjiang acutekidneyinjuryofintravenouscolistinsulfatecomparedwithcolistimethatesodiumarealworldretrospectivecohortstudy |